ANDA 210465, held by Dr. Reddy's Laboratories. Lansoprazole.
As of Nov 21, 2026, ANDA 210465 (Lansoprazole), held by Dr. Reddy's Laboratories, was first approved by FDA on Feb 1, 2021, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 1, 2021 | Original application | Approved | None posted |
| Lansoprazole15MG · tablet, orally disintegrating, delayed release;oral | Lansoprazole | Rx |
| Lansoprazole30MG · tablet, orally disintegrating, delayed release;oral | Lansoprazole | Rx |
| Sep 19, 2023 | Supplement 1Labeling · Standard review | Approved | None posted |
| Sep 19, 2023 | Supplement 3Labeling · Standard review | Approved | None posted |
| Feb 1, 2021 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters